- Investing Ideas
- /
- South Korean Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
South Korean Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
4
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
4 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
A326030 | ₩109,200.00 | 0.5% | 21.3% | ₩8.6t | ₩125,400.00 | PE149x | E51.1% | n/a | ||
A003220 | ₩14,330.00 | 1.3% | -2.0% | ₩307.1b | ₩21,000.00 | PE19.2x | E45.8% | 2.1% | ||
A214450 | ₩243,500.00 | 1.0% | 134.6% | ₩2.5t | ₩286,500.00 | PE28.5x | E25.6% | 0.4% | ||
A009420 | ₩41,150.00 | 1.9% | 42.4% | ₩2.1t | ₩53,285.71 | PS15.5x | E59.3% | n/a |
Page 1 of 1